List of Tables
Table 1. Global GnRHa Peptide Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global GnRHa Peptide Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global GnRHa Peptide Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global GnRHa Peptide Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global GnRHa Peptide Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global GnRHa Peptide Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global GnRHa Peptide Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market GnRHa Peptide Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of GnRHa Peptide Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of GnRHa Peptide Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of GnRHa Peptide Drugs, Product Type & Application
Table 12. Global Key Manufacturers of GnRHa Peptide Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global GnRHa Peptide Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GnRHa Peptide Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global GnRHa Peptide Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global GnRHa Peptide Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global GnRHa Peptide Drugs Sales Market Share by Region (2020-2025)
Table 19. Global GnRHa Peptide Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global GnRHa Peptide Drugs Sales Market Share by Region (2026-2031)
Table 21. Global GnRHa Peptide Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global GnRHa Peptide Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global GnRHa Peptide Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global GnRHa Peptide Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America GnRHa Peptide Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America GnRHa Peptide Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America GnRHa Peptide Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America GnRHa Peptide Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America GnRHa Peptide Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe GnRHa Peptide Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe GnRHa Peptide Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe GnRHa Peptide Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe GnRHa Peptide Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe GnRHa Peptide Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific GnRHa Peptide Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific GnRHa Peptide Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific GnRHa Peptide Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific GnRHa Peptide Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific GnRHa Peptide Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America GnRHa Peptide Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America GnRHa Peptide Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America GnRHa Peptide Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America GnRHa Peptide Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America GnRHa Peptide Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa GnRHa Peptide Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa GnRHa Peptide Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa GnRHa Peptide Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa GnRHa Peptide Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa GnRHa Peptide Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global GnRHa Peptide Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global GnRHa Peptide Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global GnRHa Peptide Drugs Sales Market Share by Type (2020-2025)
Table 53. Global GnRHa Peptide Drugs Sales Market Share by Type (2026-2031)
Table 54. Global GnRHa Peptide Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global GnRHa Peptide Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global GnRHa Peptide Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global GnRHa Peptide Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global GnRHa Peptide Drugs Price (US$/Unit) by Type (2020-2025)
Table 59. Global GnRHa Peptide Drugs Price (US$/Unit) by Type (2026-2031)
Table 60. Global GnRHa Peptide Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global GnRHa Peptide Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global GnRHa Peptide Drugs Sales Market Share by Application (2020-2025)
Table 63. Global GnRHa Peptide Drugs Sales Market Share by Application (2026-2031)
Table 64. Global GnRHa Peptide Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global GnRHa Peptide Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global GnRHa Peptide Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global GnRHa Peptide Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global GnRHa Peptide Drugs Price (US$/Unit) by Application (2020-2025)
Table 69. Global GnRHa Peptide Drugs Price (US$/Unit) by Application (2026-2031)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer GnRHa Peptide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Pfizer GnRHa Peptide Drugs Product
Table 74. Pfizer Recent Developments/Updates
Table 75. AbbVie Company Information
Table 76. AbbVie Description and Business Overview
Table 77. AbbVie GnRHa Peptide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. AbbVie GnRHa Peptide Drugs Product
Table 79. AbbVie Recent Developments/Updates
Table 80. AstraZeneca Company Information
Table 81. AstraZeneca Description and Business Overview
Table 82. AstraZeneca GnRHa Peptide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. AstraZeneca GnRHa Peptide Drugs Product
Table 84. AstraZeneca Recent Developments/Updates
Table 85. Ferring Company Information
Table 86. Ferring Description and Business Overview
Table 87. Ferring GnRHa Peptide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Ferring GnRHa Peptide Drugs Product
Table 89. Ferring Recent Developments/Updates
Table 90. TerSera Therapeutics Company Information
Table 91. TerSera Therapeutics Description and Business Overview
Table 92. TerSera Therapeutics GnRHa Peptide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. TerSera Therapeutics GnRHa Peptide Drugs Product
Table 94. TerSera Therapeutics Recent Developments/Updates
Table 95. Astellas Pharma Company Information
Table 96. Astellas Pharma Description and Business Overview
Table 97. Astellas Pharma GnRHa Peptide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Astellas Pharma GnRHa Peptide Drugs Product
Table 99. Astellas Pharma Recent Developments/Updates
Table 100. Takeda Company Information
Table 101. Takeda Description and Business Overview
Table 102. Takeda GnRHa Peptide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Takeda GnRHa Peptide Drugs Product
Table 104. Takeda Recent Developments/Updates
Table 105. LIVZON Company Information
Table 106. LIVZON Description and Business Overview
Table 107. LIVZON GnRHa Peptide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. LIVZON GnRHa Peptide Drugs Product
Table 109. LIVZON Recent Developments/Updates
Table 110. Ipsen Company Information
Table 111. Ipsen Description and Business Overview
Table 112. Ipsen GnRHa Peptide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Ipsen GnRHa Peptide Drugs Product
Table 114. Ipsen Recent Developments/Updates
Table 115. Sanofi Company Information
Table 116. Sanofi Description and Business Overview
Table 117. Sanofi GnRHa Peptide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Sanofi GnRHa Peptide Drugs Product
Table 119. Sanofi Recent Developments/Updates
Table 120. Endo Company Information
Table 121. Endo Description and Business Overview
Table 122. Endo GnRHa Peptide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Endo GnRHa Peptide Drugs Product
Table 124. Endo Recent Developments/Updates
Table 125. Tocris Bioscience Company Information
Table 126. Tocris Bioscience Description and Business Overview
Table 127. Tocris Bioscience GnRHa Peptide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Tocris Bioscience GnRHa Peptide Drugs Product
Table 129. Tocris Bioscience Recent Developments/Updates
Table 130. Sigma-Aldrich Company Information
Table 131. Sigma-Aldrich Description and Business Overview
Table 132. Sigma-Aldrich GnRHa Peptide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Sigma-Aldrich GnRHa Peptide Drugs Product
Table 134. Sigma-Aldrich Recent Developments/Updates
Table 135. MedChem Express Company Information
Table 136. MedChem Express Description and Business Overview
Table 137. MedChem Express GnRHa Peptide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. MedChem Express GnRHa Peptide Drugs Product
Table 139. MedChem Express Recent Developments/Updates
Table 140. Arbor Pharmaceuticals Company Information
Table 141. Arbor Pharmaceuticals Description and Business Overview
Table 142. Arbor Pharmaceuticals GnRHa Peptide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Arbor Pharmaceuticals GnRHa Peptide Drugs Product
Table 144. Arbor Pharmaceuticals Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. GnRHa Peptide Drugs Distributors List
Table 148. GnRHa Peptide Drugs Customers List
Table 149. GnRHa Peptide Drugs Market Trends
Table 150. GnRHa Peptide Drugs Market Drivers
Table 151. GnRHa Peptide Drugs Market Challenges
Table 152. GnRHa Peptide Drugs Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of GnRHa Peptide Drugs
Figure 2. Global GnRHa Peptide Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global GnRHa Peptide Drugs Market Share by Type: 2024 & 2031
Figure 4. Prostap Product Picture
Figure 5. Zoladex Product Picture
Figure 6. Triptorelin Product Picture
Figure 7. Histrelin Product Picture
Figure 8. Nafarelin Product Picture
Figure 9. Others Product Picture
Figure 10. Global GnRHa Peptide Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 11. Global GnRHa Peptide Drugs Market Share by Application: 2024 & 2031
Figure 12. Endometriosis
Figure 13. Uterine Fibroids
Figure 14. Artificial Assisted Reproduction
Figure 15. Prostate Cancer
Figure 16. Central Precocious Puberty
Figure 17. Others
Figure 18. Global GnRHa Peptide Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global GnRHa Peptide Drugs Market Size (2020-2031) & (US$ Million)
Figure 20. Global GnRHa Peptide Drugs Sales (2020-2031) & (K Units)
Figure 21. Global GnRHa Peptide Drugs Average Price (US$/Unit) & (2020-2031)
Figure 22. GnRHa Peptide Drugs Report Years Considered
Figure 23. GnRHa Peptide Drugs Sales Share by Manufacturers in 2024
Figure 24. Global GnRHa Peptide Drugs Revenue Share by Manufacturers in 2024
Figure 25. Global 5 and 10 Largest GnRHa Peptide Drugs Players: Market Share by Revenue in GnRHa Peptide Drugs in 2024
Figure 26. GnRHa Peptide Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 27. Global GnRHa Peptide Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 28. North America GnRHa Peptide Drugs Sales Market Share by Country (2020-2031)
Figure 29. North America GnRHa Peptide Drugs Revenue Market Share by Country (2020-2031)
Figure 30. United States GnRHa Peptide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Canada GnRHa Peptide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Europe GnRHa Peptide Drugs Sales Market Share by Country (2020-2031)
Figure 33. Europe GnRHa Peptide Drugs Revenue Market Share by Country (2020-2031)
Figure 34. Germany GnRHa Peptide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. France GnRHa Peptide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. U.K. GnRHa Peptide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Italy GnRHa Peptide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Russia GnRHa Peptide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Asia Pacific GnRHa Peptide Drugs Sales Market Share by Region (2020-2031)
Figure 40. Asia Pacific GnRHa Peptide Drugs Revenue Market Share by Region (2020-2031)
Figure 41. China GnRHa Peptide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Japan GnRHa Peptide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. South Korea GnRHa Peptide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. India GnRHa Peptide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Australia GnRHa Peptide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. China Taiwan GnRHa Peptide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Southeast Asia GnRHa Peptide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Latin America GnRHa Peptide Drugs Sales Market Share by Country (2020-2031)
Figure 49. Latin America GnRHa Peptide Drugs Revenue Market Share by Country (2020-2031)
Figure 50. Mexico GnRHa Peptide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Brazil GnRHa Peptide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Argentina GnRHa Peptide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Middle East and Africa GnRHa Peptide Drugs Sales Market Share by Country (2020-2031)
Figure 54. Middle East and Africa GnRHa Peptide Drugs Revenue Market Share by Country (2020-2031)
Figure 55. Turkey GnRHa Peptide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia GnRHa Peptide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. UAE GnRHa Peptide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Global Sales Market Share of GnRHa Peptide Drugs by Type (2020-2031)
Figure 59. Global Revenue Market Share of GnRHa Peptide Drugs by Type (2020-2031)
Figure 60. Global GnRHa Peptide Drugs Price (US$/Unit) by Type (2020-2031)
Figure 61. Global Sales Market Share of GnRHa Peptide Drugs by Application (2020-2031)
Figure 62. Global Revenue Market Share of GnRHa Peptide Drugs by Application (2020-2031)
Figure 63. Global GnRHa Peptide Drugs Price (US$/Unit) by Application (2020-2031)
Figure 64. GnRHa Peptide Drugs Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
